News

New publication for the ETOP CHESS trial.

Out now in Lung Cancer Journal

Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial. Cohort 2 with Tremelimumab in addition to Durvalumab is still recruiting.